0001127602-22-005319.txt : 20220216 0001127602-22-005319.hdr.sgml : 20220216 20220216165015 ACCESSION NUMBER: 0001127602-22-005319 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220214 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arnold Wendy S CENTRAL INDEX KEY: 0001802649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 22644301 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-14 0001703647 Frequency Therapeutics, Inc. FREQ 0001802649 Arnold Wendy S 75 HAYDEN AVE SUITE 300 LEXINGTON MA 02421 1 Chief People Officer Common Stock 2022-02-14 4 M 0 15000 A 17702 D Common Stock 2022-02-15 4 S 0 1168 4.331 D 16534 D Restricted Stock Unit 2022-02-14 4 M 0 15000 D Common Stock 15000 15000 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Includes 2,702 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2021. Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.28 to $4.40. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022. /s/ James P. Abely, Attorney-in-Fact for Wendy S. Arnold 2022-02-16 EX-24 2 doc1.txt POWER OF ATTORNEY (PUBLIC): EXHIBIT 24 POWER OF ATTORNEY With respect to holdings of and transactions in securities issued by Frequency Therapeutics, Inc. (the ?Company?), the undersigned hereby constitutes and appo ints the individuals named on Schedule A attached hereto and as may be amended from time to time, or any of them signing singly, with full power of substituti on and resubstitution, to act as the undersigned?s true and lawful attorney-in- fact to: 1. prepare, execute in the undersigned?s name and on the undersigned?s beha lf, and submit to the United States Securities and Exchange Commission (the ?SEC?) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain and/or regenerate codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC; 2. execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder; 3. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and 4. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to , in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact?s discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned?s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned?s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 4th day of February, 2020. Signature: /s/ Wendy S. Arnold Print Name: Wendy S. Arnold Schedule A Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and Resubstitution Peter Pfreundschuh James P. Abely